Jessica Jones-Carson
Concepts (297)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide | 16 | 2020 | 899 | 2.060 |
Why?
| | Salmonella typhimurium | 15 | 2024 | 190 | 1.230 |
Why?
| | Salmonella | 4 | 2020 | 63 | 0.990 |
Why?
| | Burkholderia pseudomallei | 3 | 2014 | 10 | 0.890 |
Why?
| | Salmonella enterica | 5 | 2016 | 57 | 0.810 |
Why?
| | Bacterial Proteins | 16 | 2020 | 944 | 0.730 |
Why?
| | Cytokinesis | 1 | 2020 | 51 | 0.610 |
Why?
| | Bacillus subtilis | 1 | 2020 | 68 | 0.600 |
Why?
| | Cytochrome d Group | 1 | 2016 | 2 | 0.520 |
Why?
| | Cytochrome b Group | 1 | 2016 | 22 | 0.510 |
Why?
| | Candidiasis | 8 | 2000 | 62 | 0.480 |
Why?
| | Escherichia coli | 1 | 2020 | 834 | 0.460 |
Why?
| | Interferon-gamma | 8 | 2014 | 791 | 0.450 |
Why?
| | Macrophages | 7 | 2014 | 1507 | 0.440 |
Why?
| | Imipenem | 1 | 2014 | 15 | 0.440 |
Why?
| | Anti-Bacterial Agents | 3 | 2014 | 1910 | 0.410 |
Why?
| | Candida albicans | 7 | 2000 | 59 | 0.390 |
Why?
| | Oxygen | 2 | 2016 | 998 | 0.390 |
Why?
| | Salmonella Infections | 4 | 2013 | 60 | 0.380 |
Why?
| | NADPH Oxidases | 6 | 2024 | 131 | 0.370 |
Why?
| | Burkholderia mallei | 2 | 2011 | 7 | 0.370 |
Why?
| | Gene Expression Regulation, Bacterial | 5 | 2018 | 327 | 0.360 |
Why?
| | Iron-Sulfur Proteins | 2 | 2008 | 47 | 0.330 |
Why?
| | Energy Metabolism | 1 | 2016 | 942 | 0.330 |
Why?
| | Immunologic Memory | 2 | 2007 | 365 | 0.320 |
Why?
| | Macrophages, Peritoneal | 10 | 2011 | 89 | 0.310 |
Why?
| | Phagosomes | 4 | 2020 | 41 | 0.290 |
Why?
| | Gastric Mucosa | 2 | 2007 | 53 | 0.290 |
Why?
| | Mice | 40 | 2024 | 18414 | 0.280 |
Why?
| | Proton-Motive Force | 2 | 2020 | 8 | 0.270 |
Why?
| | Phagocytes | 3 | 2024 | 84 | 0.250 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2005 | 335 | 0.230 |
Why?
| | Oxygen Consumption | 2 | 2020 | 718 | 0.230 |
Why?
| | Animals | 41 | 2024 | 38066 | 0.220 |
Why?
| | Endotoxemia | 1 | 2005 | 87 | 0.220 |
Why?
| | Salmonella Infections, Animal | 7 | 2010 | 38 | 0.220 |
Why?
| | Repressor Proteins | 3 | 2013 | 438 | 0.210 |
Why?
| | Membrane Proteins | 3 | 2007 | 1177 | 0.210 |
Why?
| | T-Lymphocytes | 4 | 2004 | 2036 | 0.210 |
Why?
| | Immunity, Innate | 8 | 2020 | 861 | 0.200 |
Why?
| | Methionine | 1 | 2024 | 158 | 0.200 |
Why?
| | Shock, Septic | 1 | 2005 | 219 | 0.190 |
Why?
| | Mice, Knockout | 13 | 2008 | 3112 | 0.190 |
Why?
| | Mice, Inbred C57BL | 18 | 2018 | 6055 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2005 | 399 | 0.180 |
Why?
| | Guanosine Tetraphosphate | 2 | 2020 | 5 | 0.180 |
Why?
| | Immunocompromised Host | 3 | 1999 | 206 | 0.180 |
Why?
| | Anaerobiosis | 4 | 2024 | 65 | 0.180 |
Why?
| | Genomic Islands | 2 | 2018 | 9 | 0.160 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2007 | 928 | 0.160 |
Why?
| | Aconitate Hydratase | 2 | 2012 | 17 | 0.160 |
Why?
| | T-Lymphocyte Subsets | 3 | 2000 | 422 | 0.160 |
Why?
| | Ligases | 1 | 2020 | 36 | 0.160 |
Why?
| | Pyrophosphatases | 1 | 2020 | 26 | 0.160 |
Why?
| | Cytoskeletal Proteins | 1 | 2020 | 154 | 0.150 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 2 | 1999 | 101 | 0.150 |
Why?
| | Stress, Physiological | 3 | 2018 | 453 | 0.150 |
Why?
| | Electron Transport Chain Complex Proteins | 2 | 2016 | 20 | 0.150 |
Why?
| | Immunity, Mucosal | 3 | 2004 | 99 | 0.140 |
Why?
| | Virulence Factors | 3 | 2018 | 172 | 0.140 |
Why?
| | Nitrosative Stress | 1 | 2018 | 4 | 0.140 |
Why?
| | Escherichia coli Infections | 1 | 1999 | 119 | 0.140 |
Why?
| | Immunologic Deficiency Syndromes | 2 | 1995 | 71 | 0.140 |
Why?
| | Microbial Viability | 4 | 2018 | 92 | 0.130 |
Why?
| | Regulon | 3 | 2018 | 36 | 0.130 |
Why?
| | Nucleotides | 1 | 2018 | 126 | 0.130 |
Why?
| | Oxidative Stress | 4 | 2014 | 1376 | 0.130 |
Why?
| | Oxidation-Reduction | 3 | 2016 | 1091 | 0.130 |
Why?
| | Macrophage Activation | 6 | 2008 | 192 | 0.130 |
Why?
| | Urinary Tract Infections | 1 | 1999 | 200 | 0.120 |
Why?
| | Oxidoreductases | 1 | 2016 | 95 | 0.120 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 1995 | 4 | 0.120 |
Why?
| | Candidiasis, Oral | 1 | 1995 | 19 | 0.120 |
Why?
| | B-Lymphocytes | 3 | 1999 | 884 | 0.110 |
Why?
| | Transcription Factors | 4 | 2018 | 1754 | 0.110 |
Why?
| | Transforming Growth Factor beta | 3 | 2005 | 484 | 0.100 |
Why?
| | Germ-Free Life | 4 | 1997 | 33 | 0.100 |
Why?
| | Microbial Sensitivity Tests | 2 | 2012 | 372 | 0.100 |
Why?
| | Mice, Mutant Strains | 6 | 2007 | 309 | 0.100 |
Why?
| | Reactive Oxygen Species | 4 | 2012 | 643 | 0.100 |
Why?
| | Neutrophils | 4 | 1999 | 1134 | 0.090 |
Why?
| | Oxidants | 1 | 2012 | 104 | 0.090 |
Why?
| | Nitroso Compounds | 1 | 2012 | 7 | 0.090 |
Why?
| | Melioidosis | 1 | 2012 | 5 | 0.090 |
Why?
| | Nitric Oxide Donors | 1 | 2012 | 21 | 0.090 |
Why?
| | Spermine | 1 | 2012 | 30 | 0.090 |
Why?
| | Superoxides | 4 | 2008 | 208 | 0.090 |
Why?
| | Respiratory Burst | 3 | 2008 | 19 | 0.090 |
Why?
| | Membrane Glycoproteins | 3 | 2008 | 498 | 0.090 |
Why?
| | Receptors, Cell Surface | 2 | 2004 | 379 | 0.090 |
Why?
| | Culture Media | 1 | 2012 | 165 | 0.090 |
Why?
| | Alanine Racemase | 1 | 2011 | 2 | 0.090 |
Why?
| | DNA-Binding Proteins | 2 | 2010 | 1524 | 0.090 |
Why?
| | Nitric Oxide Synthase Type II | 5 | 2013 | 172 | 0.080 |
Why?
| | Glutathione | 1 | 2012 | 373 | 0.080 |
Why?
| | Sulfhydryl Compounds | 1 | 2012 | 190 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2014 | 4183 | 0.080 |
Why?
| | Virulence | 4 | 2020 | 275 | 0.080 |
Why?
| | Mice, Inbred BALB C | 6 | 2002 | 1272 | 0.080 |
Why?
| | Hypoxia | 1 | 2016 | 1185 | 0.070 |
Why?
| | Nitric Oxide Synthase | 3 | 2000 | 241 | 0.070 |
Why?
| | NADPH Dehydrogenase | 1 | 2008 | 6 | 0.070 |
Why?
| | Trans-Activators | 1 | 2010 | 402 | 0.070 |
Why?
| | Peroxiredoxins | 1 | 2008 | 26 | 0.070 |
Why?
| | Spleen | 3 | 2000 | 517 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2005 | 1228 | 0.070 |
Why?
| | Disease Models, Animal | 4 | 2020 | 4538 | 0.070 |
Why?
| | Nitrogen Oxides | 1 | 2007 | 54 | 0.070 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2007 | 27 | 0.070 |
Why?
| | Lipopolysaccharides | 4 | 2005 | 861 | 0.060 |
Why?
| | Survival Analysis | 2 | 2010 | 1332 | 0.060 |
Why?
| | Organ Specificity | 1 | 2007 | 311 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2008 | 339 | 0.060 |
Why?
| | Genes, Bacterial | 4 | 2011 | 165 | 0.060 |
Why?
| | Models, Genetic | 1 | 2008 | 593 | 0.060 |
Why?
| | Anti-Infective Agents | 1 | 2008 | 243 | 0.060 |
Why?
| | Mutation | 4 | 2011 | 4059 | 0.050 |
Why?
| | Phagocytosis | 3 | 2004 | 291 | 0.050 |
Why?
| | Kupffer Cells | 1 | 2004 | 49 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 209 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2944 | 0.050 |
Why?
| | Leptin | 2 | 2004 | 239 | 0.050 |
Why?
| | Stomach | 2 | 2000 | 117 | 0.050 |
Why?
| | Sigma Factor | 1 | 2002 | 43 | 0.040 |
Why?
| | Disease Susceptibility | 2 | 2004 | 354 | 0.040 |
Why?
| | Colitis | 1 | 2004 | 281 | 0.040 |
Why?
| | ADP Ribose Transferases | 1 | 2000 | 9 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1831 | 0.040 |
Why?
| | Guanosine Pentaphosphate | 1 | 2020 | 4 | 0.040 |
Why?
| | Hydroxides | 1 | 2000 | 27 | 0.040 |
Why?
| | Cell Survival | 2 | 2020 | 1136 | 0.040 |
Why?
| | Immunity, Cellular | 3 | 1999 | 269 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2000 | 124 | 0.040 |
Why?
| | CD18 Antigens | 1 | 1999 | 22 | 0.040 |
Why?
| | Gram-Positive Bacteria | 1 | 2020 | 48 | 0.040 |
Why?
| | Mice, Inbred MRL lpr | 1 | 1999 | 37 | 0.040 |
Why?
| | Transcription Factor RelA | 1 | 2020 | 87 | 0.040 |
Why?
| | Liver | 4 | 2004 | 1869 | 0.040 |
Why?
| | Gene Deletion | 2 | 2011 | 394 | 0.040 |
Why?
| | Bacterial Toxins | 1 | 2000 | 106 | 0.040 |
Why?
| | Gram-Negative Bacteria | 1 | 2020 | 80 | 0.040 |
Why?
| | Humans | 7 | 2024 | 143807 | 0.040 |
Why?
| | Receptors, Interleukin | 1 | 1999 | 45 | 0.040 |
Why?
| | Mucous Membrane | 1 | 2000 | 127 | 0.040 |
Why?
| | Intestinal Diseases | 1 | 1999 | 42 | 0.040 |
Why?
| | Interleukin-18 | 1 | 2000 | 236 | 0.040 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2000 | 146 | 0.030 |
Why?
| | Type III Secretion Systems | 1 | 2018 | 14 | 0.030 |
Why?
| | Antioxidants | 1 | 2002 | 594 | 0.030 |
Why?
| | Esophagus | 1 | 2000 | 268 | 0.030 |
Why?
| | Mice, Inbred C3H | 2 | 2010 | 257 | 0.030 |
Why?
| | Antigens, Fungal | 1 | 1997 | 27 | 0.030 |
Why?
| | Interleukin-10 | 1 | 1999 | 311 | 0.030 |
Why?
| | beta 2-Microglobulin | 1 | 1996 | 49 | 0.030 |
Why?
| | Lymphocyte Activation | 2 | 1999 | 1143 | 0.030 |
Why?
| | Wound Healing | 1 | 1999 | 357 | 0.030 |
Why?
| | Intestines | 1 | 1999 | 357 | 0.030 |
Why?
| | Mice, Nude | 2 | 1995 | 710 | 0.030 |
Why?
| | Antigens, CD | 1 | 1999 | 549 | 0.030 |
Why?
| | Nitrates | 1 | 1996 | 97 | 0.030 |
Why?
| | Immunophenotyping | 1 | 1997 | 326 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2000 | 727 | 0.030 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 18 | 0.030 |
Why?
| | Antifungal Agents | 1 | 1996 | 147 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2011 | 1062 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 1995 | 59 | 0.030 |
Why?
| | Histocompatibility Antigens Class I | 1 | 1996 | 208 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 1995 | 1372 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 1995 | 136 | 0.030 |
Why?
| | NADPH Oxidase 2 | 2 | 2008 | 36 | 0.030 |
Why?
| | Kidney | 2 | 2000 | 1507 | 0.030 |
Why?
| | Immunocompetence | 1 | 1994 | 47 | 0.030 |
Why?
| | Cell Separation | 1 | 1995 | 311 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2013 | 1314 | 0.030 |
Why?
| | Arginine | 1 | 1995 | 261 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1263 | 0.030 |
Why?
| | Nitrosation | 1 | 2012 | 8 | 0.020 |
Why?
| | Reactive Nitrogen Species | 1 | 2012 | 19 | 0.020 |
Why?
| | Molecular Weight | 1 | 2012 | 326 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 2005 | 415 | 0.020 |
Why?
| | Gene Expression Profiling | 2 | 2011 | 1794 | 0.020 |
Why?
| | Periodic Acid | 1 | 2011 | 2 | 0.020 |
Why?
| | Base Sequence | 1 | 1995 | 2200 | 0.020 |
Why?
| | Microscopy, Fluorescence | 2 | 2005 | 420 | 0.020 |
Why?
| | Flow Cytometry | 1 | 1995 | 1192 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 118 | 0.020 |
Why?
| | Operon | 1 | 2010 | 69 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2011 | 367 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2010 | 140 | 0.020 |
Why?
| | Alanine | 1 | 2011 | 171 | 0.020 |
Why?
| | Genetic Markers | 1 | 2011 | 345 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2010 | 117 | 0.020 |
Why?
| | Plasmids | 1 | 2011 | 371 | 0.020 |
Why?
| | Brain | 2 | 2000 | 2899 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2011 | 186 | 0.020 |
Why?
| | Genetic Loci | 1 | 2011 | 279 | 0.020 |
Why?
| | Immunity | 1 | 2010 | 139 | 0.020 |
Why?
| | Mice, SCID | 2 | 2004 | 373 | 0.020 |
Why?
| | Inflammation | 2 | 1999 | 2882 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2010 | 333 | 0.020 |
Why?
| | Time Factors | 1 | 2000 | 7039 | 0.020 |
Why?
| | Apoptosis | 1 | 1997 | 2519 | 0.020 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 13 | 0.020 |
Why?
| | Flavoproteins | 1 | 2007 | 8 | 0.020 |
Why?
| | Hemeproteins | 1 | 2007 | 8 | 0.020 |
Why?
| | Drug Resistance, Microbial | 1 | 2008 | 67 | 0.020 |
Why?
| | Concanavalin A | 2 | 2000 | 72 | 0.020 |
Why?
| | Succinate Dehydrogenase | 1 | 2007 | 52 | 0.020 |
Why?
| | Gangliosides | 1 | 2007 | 23 | 0.020 |
Why?
| | Guanidines | 2 | 1999 | 42 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 2167 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2010 | 369 | 0.020 |
Why?
| | Interleukin-4 | 2 | 1999 | 216 | 0.020 |
Why?
| | Sphingolipids | 1 | 2007 | 82 | 0.020 |
Why?
| | Cytosol | 1 | 2007 | 225 | 0.020 |
Why?
| | Ceramides | 1 | 2007 | 117 | 0.020 |
Why?
| | Antibody Formation | 2 | 1999 | 297 | 0.020 |
Why?
| | Acute Disease | 2 | 1999 | 1015 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2005 | 277 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 2007 | 203 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 763 | 0.010 |
Why?
| | Receptors, Leptin | 1 | 2004 | 25 | 0.010 |
Why?
| | Mice, Congenic | 1 | 2004 | 23 | 0.010 |
Why?
| | Lymphocyte Transfusion | 1 | 2004 | 20 | 0.010 |
Why?
| | RNA, Bacterial | 1 | 2005 | 191 | 0.010 |
Why?
| | Protein Binding | 1 | 2010 | 2265 | 0.010 |
Why?
| | Leukocyte Common Antigens | 1 | 2004 | 88 | 0.010 |
Why?
| | Chemokines, CXC | 1 | 2004 | 70 | 0.010 |
Why?
| | Female | 7 | 2011 | 77403 | 0.010 |
Why?
| | Neutrophil Infiltration | 1 | 2004 | 105 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2004 | 222 | 0.010 |
Why?
| | Intestinal Mucosa | 2 | 1999 | 665 | 0.010 |
Why?
| | Th1 Cells | 1 | 2004 | 140 | 0.010 |
Why?
| | Corticosterone | 1 | 2004 | 240 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2004 | 189 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3381 | 0.010 |
Why?
| | Aerobiosis | 1 | 2002 | 22 | 0.010 |
Why?
| | Toll-Like Receptor 4 | 1 | 2004 | 276 | 0.010 |
Why?
| | Exotoxins | 1 | 2000 | 16 | 0.010 |
Why?
| | Peroxides | 1 | 2000 | 18 | 0.010 |
Why?
| | Cerium | 1 | 2000 | 18 | 0.010 |
Why?
| | Mice, Obese | 1 | 2000 | 66 | 0.010 |
Why?
| | Vacuoles | 1 | 2000 | 39 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 806 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2000 | 154 | 0.010 |
Why?
| | 3-Phosphoshikimate 1-Carboxyvinyltransferase | 1 | 1999 | 2 | 0.010 |
Why?
| | Luminol | 1 | 1999 | 1 | 0.010 |
Why?
| | Receptors, Interleukin-8A | 1 | 1999 | 5 | 0.010 |
Why?
| | Alkyl and Aryl Transferases | 1 | 1999 | 31 | 0.010 |
Why?
| | Tyrosine | 1 | 2000 | 229 | 0.010 |
Why?
| | Transplantation Chimera | 1 | 1999 | 57 | 0.010 |
Why?
| | Fimbriae, Bacterial | 1 | 1999 | 34 | 0.010 |
Why?
| | Indicators and Reagents | 1 | 1999 | 109 | 0.010 |
Why?
| | Lymphocyte Cooperation | 1 | 1999 | 49 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 1999 | 203 | 0.010 |
Why?
| | Luminescent Measurements | 1 | 1999 | 76 | 0.010 |
Why?
| | Transplantation Immunology | 1 | 1999 | 31 | 0.010 |
Why?
| | Mutagenesis | 1 | 1999 | 184 | 0.010 |
Why?
| | Biological Transport | 1 | 1999 | 412 | 0.010 |
Why?
| | Bone Marrow Transplantation | 1 | 1999 | 292 | 0.010 |
Why?
| | Major Histocompatibility Complex | 1 | 1999 | 233 | 0.010 |
Why?
| | Chronic Disease | 1 | 2004 | 1834 | 0.010 |
Why?
| | Stomach Ulcer | 1 | 1997 | 15 | 0.010 |
Why?
| | Ulcer | 1 | 1997 | 34 | 0.010 |
Why?
| | Bacteremia | 1 | 1999 | 219 | 0.010 |
Why?
| | Hyperplasia | 1 | 1997 | 175 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1999 | 639 | 0.010 |
Why?
| | Opsonin Proteins | 1 | 1996 | 20 | 0.010 |
Why?
| | Digestive System Diseases | 1 | 1996 | 27 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 1997 | 408 | 0.010 |
Why?
| | Inflammation Mediators | 1 | 1999 | 510 | 0.010 |
Why?
| | Glucans | 1 | 1996 | 21 | 0.010 |
Why?
| | Immune Tolerance | 1 | 1999 | 384 | 0.010 |
Why?
| | Disease Progression | 1 | 2004 | 2862 | 0.010 |
Why?
| | Cytokines | 1 | 2004 | 2099 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 1999 | 417 | 0.010 |
Why?
| | omega-N-Methylarginine | 1 | 1995 | 29 | 0.010 |
Why?
| | Longevity | 1 | 1997 | 175 | 0.010 |
Why?
| | Infusions, Intravenous | 1 | 1996 | 423 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 1999 | 475 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2004 | 2423 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 840 | 0.010 |
Why?
| | Nitroprusside | 1 | 1995 | 72 | 0.010 |
Why?
| | Male | 5 | 2004 | 71658 | 0.010 |
Why?
| | Nitrites | 1 | 1995 | 88 | 0.010 |
Why?
| | Homeostasis | 1 | 1999 | 641 | 0.010 |
Why?
| | Thioglycolates | 1 | 1994 | 3 | 0.010 |
Why?
| | Genotype | 1 | 1999 | 1877 | 0.010 |
Why?
| | Blotting, Western | 1 | 1996 | 1223 | 0.010 |
Why?
| | Chemotaxis | 1 | 1994 | 122 | 0.010 |
Why?
| | Pneumonia | 1 | 1999 | 647 | 0.010 |
Why?
| | Superoxide Dismutase | 1 | 1994 | 346 | 0.010 |
Why?
| | Hot Temperature | 1 | 1994 | 408 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1995 | 2057 | 0.010 |
Why?
| | Signal Transduction | 1 | 2004 | 5220 | 0.010 |
Why?
| | Aging | 1 | 1999 | 1955 | 0.000 |
Why?
| | Gene Expression Regulation | 1 | 1996 | 2621 | 0.000 |
Why?
|
|
Jones-Carson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|